Intelligent Bio Solutions Inc. (INBS)
USD 1.27
(-6.62%)
USD 1.27
(-6.62%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.57 Million | -7.37 Million | -3.35 Million | -11.29 Million | -498.61 Thousand | -5.57 Million |
| Net Income | -10.19 Million | -10.66 Million | -8.33 Million | -7.06 Million | -3.16 Million | -7.39 Million |
| Depreciation & Amortization | 1.21 Million | 966.73 Thousand | - | - | - | - |
| Deferred income taxes | - | 3.74 Million | - | - | - | - |
| Stock-based compensation | 230.49 Thousand | 260 Thousand | - | - | 900 Thousand | 1.95 Million |
| Change in working capital | -701.92 Thousand | 78.91 Thousand | 2.43 Million | -4.94 Million | 1.4 Million | -132.8 Thousand |
| Other non-cash items | -24.17 Thousand | -1.75 Million | 2.53 Million | 704.36 Thousand | 360.59 Thousand | 1.89 Million |
| Investing Cash Flow | -221.42 Thousand | -694.14 Thousand | -880.22 Thousand | - | -14 Thousand | - |
| Investments in PPE | -221.42 Thousand | -505.12 Thousand | -380.22 Thousand | - | - | - |
| Acquisitions | - | -189.01 Thousand | - | - | -14 Thousand | - |
| Investment purchases | - | - | -500 Thousand | - | -14 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -216.05 Thousand | -868.62 Thousand | -500 Thousand | - | 14 Thousand | - |
| Financing Cash Flow | 14.56 Million | 1.43 Million | - | 23.4 Million | 733.86 Thousand | 5.31 Million |
| Debt repayment | - | - | - | - | -150.98 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -14.4 Thousand | - | - | - | - |
| Common Stock Issuance | 12.9 Million | 2.55 Million | - | 21.6 Million | 884.84 Thousand | 5.31 Million |
| Other Financing Activities | 10.77 Million | -1.1 Million | - | 1.8 Million | -116.4 Thousand | 5.31 Million |
| Accounts receivables | -135.84 Thousand | -293.86 Thousand | 2.5 Million | -1.02 Million | 50.41 Thousand | - |
| Accounts payables | -632.95 Thousand | 84.5 Thousand | 242.65 Thousand | -972.99 Thousand | 1.35 Million | -132.8 Thousand |
| Inventory | 202.37 Thousand | -345.39 Thousand | -2.5 Million | 1.02 Million | -99.27 Thousand | - |
| Other working capital | -257.54 Thousand | 554.74 Thousand | 2.19 Million | -3.96 Million | 99.27 Thousand | -132.8 Thousand |
| Cash at beginning of period | 1.53 Million | 8.23 Million | 12.57 Million | 427.27 Thousand | 197.94 Thousand | 418.42 Thousand |
| Cash at end of period | 6.3 Million | 1.53 Million | 8.23 Million | 12.57 Million | 427.27 Thousand | 197.94 Thousand |
| Capital Expenditure | -221.42 Thousand | -505.12 Thousand | -380.22 Thousand | - | - | - |
| Effect of forex changes on cash | -707.00 | -64.86 Thousand | -97.12 Thousand | 39.97 Thousand | 8089.00 | 37.79 Thousand |
| Net cash flow / Change in cash | 4.76 Million | -6.7 Million | -4.33 Million | 12.14 Million | 229.33 Thousand | -220.48 Thousand |
| Free Cash Flow | -9.79 Million | -7.88 Million | -3.73 Million | -11.29 Million | -498.61 Thousand | -5.57 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.19 Million | -2.79 Million | -2.97 Million | -1.97 Million | -2.43 Million | -10.66 Million |
| Depreciation & Amortization | 1.21 Million | 287.68 Thousand | 327.52 Thousand | 290.31 Thousand | 307.56 Thousand | 966.73 Thousand |
| Deferred income taxes | - | - | - | - | - | 3.74 Million |
| Stock-based compensation | 230.49 Thousand | 12.19 Thousand | 218.3 Thousand | - | - | 260 Thousand |
| Change in working capital | - | -530.18 Thousand | 28.98 Thousand | -1 Million | 805.46 Thousand | 78.91 Thousand |
| Other non-cash items | - | 80.06 Thousand | 761.98 Thousand | -176.48 Thousand | 7563.00 | -1.75 Million |
| Investing Cash Flow | -221.42 Thousand | -167.3 Thousand | 2415.70 | -56.66 Thousand | - | -694.14 Thousand |
| Investments in PPE | -5368.00 | -167.3 Thousand | 2415.70 | -56.66 Thousand | - | -505.12 Thousand |
| Acquisitions | - | - | - | - | - | -189.01 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -216.05 Thousand | -216.05 Thousand | - | - | - | -868.62 Thousand |
| Financing Cash Flow | 14.56 Million | 5313.00 | 10.82 Million | 3.79 Million | - | 1.43 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -14.4 Thousand |
| Common Stock Issuance | 3.78 Million | -1.67 Million | 1.66 Million | 3.79 Million | - | 2.55 Million |
| Other Financing Activities | 10.77 Million | 1.62 Million | 9.15 Million | 3.78 Million | - | -1.1 Million |
| Accounts receivables | -135.84 Thousand | -69.8 Thousand | -234.25 Thousand | 304.67 Thousand | -273.64 Thousand | -293.86 Thousand |
| Accounts payables | -632.95 Thousand | -151.66 Thousand | 148.24 Thousand | -1.84 Million | 1.21 Million | 84.5 Thousand |
| Inventory | 202.37 Thousand | 100.36 Thousand | 133.59 Thousand | 21.87 Thousand | -53.03 Thousand | -345.39 Thousand |
| Other working capital | - | 394.49 Thousand | -18.59 Thousand | 513.37 Thousand | -889.28 Thousand | 554.74 Thousand |
| Cash at beginning of period | 1.53 Million | 9.39 Million | 1.11 Million | 186.4 Thousand | 1.53 Million | 8.23 Million |
| Cash at end of period | 6.3 Million | 6.3 Million | 9.39 Million | 1.11 Million | 186.4 Thousand | 1.53 Million |
| Capital Expenditure | -5368.00 | -167.3 Thousand | 2415.70 | -56.66 Thousand | - | -505.12 Thousand |
| Effect of forex changes on cash | -707.00 | 12.58 Thousand | -46.54 Thousand | 72.26 Thousand | -39.01 Thousand | -64.86 Thousand |
| Net cash flow / Change in cash | 4.76 Million | -3.09 Million | 8.27 Million | 932.6 Thousand | -1.35 Million | -6.7 Million |
| Free Cash Flow | -9.57 Million | -3.11 Million | -2.46 Million | -2.92 Million | -1.31 Million | -7.88 Million |
3296
MBI
ASMIY
FEX
PRX
035250